1 / 23

Behaviour

Diseases. Environment. Infectious diseases. Behaviour. Genetics. Drug Discovery and BioMedical research in the 21 st century? The third revolution. The first revolution: The era of incidental discoveries 1930s-1960s. Felix Hoffman. Aspirin. Penicillin. The second revolution

renjiro-wada
Download Presentation

Behaviour

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Diseases Environment Infectious diseases Behaviour Genetics

  2. Drug Discovery and BioMedical research in the 21st century? The third revolution

  3. The first revolution: The era of incidental discoveries 1930s-1960s

  4. Felix Hoffman Aspirin

  5. Penicillin

  6. The second revolution 1970s-2000s High throughput – brute force screening of large libraries of chemical compounds

  7. Statins Akira Endo

  8. Future medicine- Targeted and Personally “fitted” medicine – Personalized Medicine

  9. Medicine of the 21st Century – The 4P’s Medicine (Leroy Hood) Personalized, Predictive, Preventive, and Participatory Medicine Stem cell-based therapies

  10. Future medicine- Targeted and Personally “fitted” and medicine - Personalized Medicine Breast Cancer – Estrogen Receptor Negative and Positive (predicts sensitivity to Tamoxifen)

  11. Herceptin (targeted)

  12. Prevalence rate of ADR • Fatal ADRs appear to be between the fourthandsixth leading cause of death in the USA

  13. Factors determining inter-individual variations in drug response High/Body Weight Genetic polymorphisms Sex Environmental Factors diet / smoking / comedications Age elderly children neonates Inter-individual Variability in Drug Response Disease Process Concomitant Disease Organ Function Liver, Kidney, Cardiac

  14. To understand it by pharmacogenomics

  15. The Human Genome Size of the entire Human Genome = 3 Billion Bases

  16. Is the development of personalized drugs going to be straightforward? Here are some major obstacles Central dogma of flow of genetic information DNA (the human genome) Epigenetic control of gene expression RNA (the human transcriptome) Control by small RNAS Multiple post-translational modifications: phosphorylations, acetylations, amidations, glycosylations, ubiquitinations, etc. Proteins (the human proteome)

  17. What are the obstacles – they appear to be broader and more complicated than just target identification and validation : • Many diseases (metabolic, psychiatric) are multi-genic, and the causative connection between the genes products is not clear. We are still missing a whole body of basic knowledge. • 2. Malignancies are characterized by genomic instability and therefore targets are not stable • 3. Human experimentation is complicated (HRT, stents) • 4. Lack of faithful animal models (neurodegeneration, cancer, metabolic diseases) • Cost of developing new drugs - legal liability (Vioxx/Celebrex), markets (new antibiotics), and patents protection (AIDS - South Africa, India) • End of blockbuster drugs era • 7. Bioethical problems of availability of genetic information

More Related